NDC 57894-070 – Simponi
Golimumab 50 mg/.5mL · Injection, Solution · Subcutaneous
Product NDC57894-070
Product details
- Brand name
- Simponi
- Generic name
- Golimumab
- Labeler
- Janssen Biotech, Inc.
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA125289
- Marketed since
- April 25, 2009
- Listing expires
- December 31, 2027
- Pharmacologic class
- Tumor Necrosis Factor Blocker
Active ingredients
- Golimumab 50 mg/.5mL
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 57894-070-01 | 1 SYRINGE, GLASS in 1 CARTON (57894-070-01) / .5 mL in 1 SYRINGE, GLASS | Apr 25, 2009 |
| 57894-070-02 | 1 SYRINGE in 1 CARTON (57894-070-02) / .5 mL in 1 SYRINGE | Apr 25, 2009 |
| 57894-070-89 sample | 1 SYRINGE in 1 CARTON (57894-070-89) / .5 mL in 1 SYRINGE | Apr 25, 2009 |
| 57894-070-90 sample | 1 SYRINGE, GLASS in 1 CARTON (57894-070-90) / .5 mL in 1 SYRINGE, GLASS | Apr 25, 2009 |
Other Simponi products
- 57894-071 Golimumab 100 mg/mL · Injection, Solution · Janssen Biotech, Inc.